HEADER VIRAL PROTEIN 31-MAR-16 5J3O TITLE PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS NSW0514 IN COMPLEX WITH 3- TITLE 2 FUCOSYLLACTOSE (3FL) COMPND MOL_ID: 1; COMPND 2 MOLECULE: VP1; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOROVIRUS HU/GII.4/SYDNEY/NSW0514/2012/AU; SOURCE 3 ORGANISM_TAXID: 1241973; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: MBP-HTSHP KEYWDS VIRAL CAPSID PROTEIN, PROTRUDING DOMAIN, VIRAL PROTEIN, NOROVIRUS, KEYWDS 2 HUMAN MILK OLIGOSACCHARIDES EXPDTA X-RAY DIFFRACTION AUTHOR B.K.SINGH,G.S.HANSMAN REVDAT 3 10-JAN-24 5J3O 1 HETSYN REVDAT 2 29-JUL-20 5J3O 1 COMPND REMARK HETNAM SITE REVDAT 1 12-APR-17 5J3O 0 JRNL AUTH B.K.SINGH,G.S.HANSMAN JRNL TITL STRUCTURAL BASIS FOR GII.4 NOROVIRUS INHIBITION BY HUMAN JRNL TITL 2 MILK OLIGOSACCHARIDES. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.72 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 101291 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.7337 - 4.5658 0.95 3208 169 0.1479 0.1607 REMARK 3 2 4.5658 - 3.6246 0.99 3270 173 0.1328 0.1453 REMARK 3 3 3.6246 - 3.1666 0.99 3245 171 0.1465 0.1848 REMARK 3 4 3.1666 - 2.8772 0.99 3251 170 0.1467 0.1710 REMARK 3 5 2.8772 - 2.6710 1.00 3207 169 0.1496 0.1754 REMARK 3 6 2.6710 - 2.5135 0.99 3230 169 0.1514 0.1952 REMARK 3 7 2.5135 - 2.3877 1.00 3232 170 0.1515 0.1600 REMARK 3 8 2.3877 - 2.2837 0.99 3216 170 0.1481 0.1839 REMARK 3 9 2.2837 - 2.1958 0.99 3204 170 0.1534 0.1676 REMARK 3 10 2.1958 - 2.1201 0.99 3201 168 0.1637 0.1979 REMARK 3 11 2.1201 - 2.0538 1.00 3221 169 0.1585 0.2082 REMARK 3 12 2.0538 - 1.9951 0.99 3188 168 0.1650 0.1971 REMARK 3 13 1.9951 - 1.9425 0.99 3186 166 0.1710 0.2046 REMARK 3 14 1.9425 - 1.8951 1.00 3215 166 0.1775 0.2016 REMARK 3 15 1.8951 - 1.8521 0.99 3228 171 0.1799 0.1983 REMARK 3 16 1.8521 - 1.8126 0.99 3218 170 0.1774 0.1941 REMARK 3 17 1.8126 - 1.7764 1.00 3153 167 0.1809 0.2196 REMARK 3 18 1.7764 - 1.7429 0.99 3228 169 0.1963 0.2000 REMARK 3 19 1.7429 - 1.7117 0.99 3203 168 0.1940 0.2246 REMARK 3 20 1.7117 - 1.6827 0.99 3200 167 0.2018 0.2299 REMARK 3 21 1.6827 - 1.6556 1.00 3220 170 0.2046 0.2532 REMARK 3 22 1.6556 - 1.6301 0.99 3177 168 0.2135 0.2931 REMARK 3 23 1.6301 - 1.6061 0.99 3212 170 0.2230 0.2543 REMARK 3 24 1.6061 - 1.5835 0.99 3138 166 0.2166 0.2398 REMARK 3 25 1.5835 - 1.5621 0.99 3267 169 0.2245 0.2636 REMARK 3 26 1.5621 - 1.5418 0.99 3123 165 0.2308 0.2629 REMARK 3 27 1.5418 - 1.5225 0.99 3231 171 0.2371 0.2742 REMARK 3 28 1.5225 - 1.5042 0.99 3163 166 0.2480 0.2894 REMARK 3 29 1.5042 - 1.4867 1.00 3219 170 0.2572 0.2888 REMARK 3 30 1.4867 - 1.4700 0.99 3175 167 0.2637 0.2814 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.080 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 46.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 5210 REMARK 3 ANGLE : 1.262 7166 REMARK 3 CHIRALITY : 0.079 788 REMARK 3 PLANARITY : 0.007 962 REMARK 3 DIHEDRAL : 12.656 1946 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219897. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96770 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 137290 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.320 REMARK 200 RESOLUTION RANGE LOW (A) : 42.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.260 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4OOS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM FORMATE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.53500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.78500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.53500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.78500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 373 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 373 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 901 O HOH B 1048 2.11 REMARK 500 O HOH A 900 O HOH A 1051 2.11 REMARK 500 O HOH A 983 O HOH A 984 2.14 REMARK 500 O HOH B 981 O HOH B 982 2.14 REMARK 500 OD2 ASP A 289 O HOH A 701 2.15 REMARK 500 OD2 ASP B 289 O HOH B 701 2.15 REMARK 500 O HOH A 818 O HOH B 901 2.17 REMARK 500 O HOH A 900 O HOH B 819 2.18 REMARK 500 O HOH A 716 O HOH A 1045 2.18 REMARK 500 O HOH B 717 O HOH B 889 2.19 REMARK 500 O HOH A 1045 O HOH B 711 2.19 REMARK 500 O HOH A 710 O HOH A 878 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 260 49.45 -140.81 REMARK 500 ALA A 359 56.78 -140.42 REMARK 500 ARG A 373 -16.75 -149.87 REMARK 500 VAL A 386 -50.07 -121.07 REMARK 500 SER A 442 144.98 179.13 REMARK 500 GLN B 260 49.37 -140.60 REMARK 500 ALA B 359 56.61 -140.06 REMARK 500 ARG B 373 -16.28 -149.78 REMARK 500 VAL B 386 -50.20 -121.21 REMARK 500 SER B 442 144.63 179.25 REMARK 500 VAL B 521 -169.45 -126.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1075 DISTANCE = 6.13 ANGSTROMS REMARK 525 HOH B1072 DISTANCE = 6.13 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IYR RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH REMARK 900 2-FUCOSYLLACTOSE (2'FL) REMARK 900 RELATED ID: 5HZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 3- REMARK 900 FUCOSYLLACTOSE (3 FL) REMARK 900 RELATED ID: 5HZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 2- REMARK 900 FUCOSYLLACTOSE (2'FL) REMARK 900 RELATED ID: 4OOS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 REMARK 900 RELATED ID: 5IYW RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH REMARK 900 3-FUCOSYLLACTOSE (3FL) REMARK 900 RELATED ID: 5J35 RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS NSW0514 IN COMPLEX WITH REMARK 900 2-FUCOSYLLACTOSE (2'FL) DBREF 5J3O A 225 530 UNP K4LM89 K4LM89_9CALI 225 530 DBREF 5J3O B 225 530 UNP K4LM89 K4LM89_9CALI 225 530 SEQADV 5J3O PRO A 222 UNP K4LM89 EXPRESSION TAG SEQADV 5J3O GLY A 223 UNP K4LM89 EXPRESSION TAG SEQADV 5J3O SER A 224 UNP K4LM89 EXPRESSION TAG SEQADV 5J3O PRO B 222 UNP K4LM89 EXPRESSION TAG SEQADV 5J3O GLY B 223 UNP K4LM89 EXPRESSION TAG SEQADV 5J3O SER B 224 UNP K4LM89 EXPRESSION TAG SEQRES 1 A 309 PRO GLY SER LYS PRO PHE SER VAL PRO VAL LEU THR VAL SEQRES 2 A 309 GLU GLU MET THR ASN SER ARG PHE PRO ILE PRO LEU GLU SEQRES 3 A 309 LYS LEU PHE THR GLY PRO SER SER ALA PHE VAL VAL GLN SEQRES 4 A 309 PRO GLN ASN GLY ARG CYS THR THR ASP GLY VAL LEU LEU SEQRES 5 A 309 GLY THR THR GLN LEU SER PRO VAL ASN ILE CYS THR PHE SEQRES 6 A 309 ARG GLY ASP VAL THR HIS ILE THR GLY SER ARG ASN TYR SEQRES 7 A 309 THR MET ASN LEU ALA SER GLN ASN TRP ASN ASP TYR ASP SEQRES 8 A 309 PRO THR GLU GLU ILE PRO ALA PRO LEU GLY THR PRO ASP SEQRES 9 A 309 PHE VAL GLY LYS ILE GLN GLY VAL LEU THR GLN THR THR SEQRES 10 A 309 ARG THR ASP GLY SER THR ARG GLY HIS LYS ALA THR VAL SEQRES 11 A 309 TYR THR GLY SER ALA ASP PHE ALA PRO LYS LEU GLY ARG SEQRES 12 A 309 VAL GLN PHE GLU THR ASP THR ASP ARG ASP PHE GLU ALA SEQRES 13 A 309 ASN GLN ASN THR LYS PHE THR PRO VAL GLY VAL ILE GLN SEQRES 14 A 309 ASP GLY GLY THR THR HIS ARG ASN GLU PRO GLN GLN TRP SEQRES 15 A 309 VAL LEU PRO SER TYR SER GLY ARG ASN THR HIS ASN VAL SEQRES 16 A 309 HIS LEU ALA PRO ALA VAL ALA PRO THR PHE PRO GLY GLU SEQRES 17 A 309 GLN LEU LEU PHE PHE ARG SER THR MET PRO GLY CYS SER SEQRES 18 A 309 GLY TYR PRO ASN MET ASP LEU ASP CYS LEU LEU PRO GLN SEQRES 19 A 309 GLU TRP VAL GLN TYR PHE TYR GLN GLU ALA ALA PRO ALA SEQRES 20 A 309 GLN SER ASP VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP SEQRES 21 A 309 THR GLY ARG VAL LEU PHE GLU CYS LYS LEU HIS LYS SER SEQRES 22 A 309 GLY TYR VAL THR VAL ALA HIS THR GLY GLN HIS ASP LEU SEQRES 23 A 309 VAL ILE PRO PRO ASN GLY TYR PHE ARG PHE ASP SER TRP SEQRES 24 A 309 VAL ASN GLN PHE TYR THR LEU ALA PRO MET SEQRES 1 B 309 PRO GLY SER LYS PRO PHE SER VAL PRO VAL LEU THR VAL SEQRES 2 B 309 GLU GLU MET THR ASN SER ARG PHE PRO ILE PRO LEU GLU SEQRES 3 B 309 LYS LEU PHE THR GLY PRO SER SER ALA PHE VAL VAL GLN SEQRES 4 B 309 PRO GLN ASN GLY ARG CYS THR THR ASP GLY VAL LEU LEU SEQRES 5 B 309 GLY THR THR GLN LEU SER PRO VAL ASN ILE CYS THR PHE SEQRES 6 B 309 ARG GLY ASP VAL THR HIS ILE THR GLY SER ARG ASN TYR SEQRES 7 B 309 THR MET ASN LEU ALA SER GLN ASN TRP ASN ASP TYR ASP SEQRES 8 B 309 PRO THR GLU GLU ILE PRO ALA PRO LEU GLY THR PRO ASP SEQRES 9 B 309 PHE VAL GLY LYS ILE GLN GLY VAL LEU THR GLN THR THR SEQRES 10 B 309 ARG THR ASP GLY SER THR ARG GLY HIS LYS ALA THR VAL SEQRES 11 B 309 TYR THR GLY SER ALA ASP PHE ALA PRO LYS LEU GLY ARG SEQRES 12 B 309 VAL GLN PHE GLU THR ASP THR ASP ARG ASP PHE GLU ALA SEQRES 13 B 309 ASN GLN ASN THR LYS PHE THR PRO VAL GLY VAL ILE GLN SEQRES 14 B 309 ASP GLY GLY THR THR HIS ARG ASN GLU PRO GLN GLN TRP SEQRES 15 B 309 VAL LEU PRO SER TYR SER GLY ARG ASN THR HIS ASN VAL SEQRES 16 B 309 HIS LEU ALA PRO ALA VAL ALA PRO THR PHE PRO GLY GLU SEQRES 17 B 309 GLN LEU LEU PHE PHE ARG SER THR MET PRO GLY CYS SER SEQRES 18 B 309 GLY TYR PRO ASN MET ASP LEU ASP CYS LEU LEU PRO GLN SEQRES 19 B 309 GLU TRP VAL GLN TYR PHE TYR GLN GLU ALA ALA PRO ALA SEQRES 20 B 309 GLN SER ASP VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP SEQRES 21 B 309 THR GLY ARG VAL LEU PHE GLU CYS LYS LEU HIS LYS SER SEQRES 22 B 309 GLY TYR VAL THR VAL ALA HIS THR GLY GLN HIS ASP LEU SEQRES 23 B 309 VAL ILE PRO PRO ASN GLY TYR PHE ARG PHE ASP SER TRP SEQRES 24 B 309 VAL ASN GLN PHE TYR THR LEU ALA PRO MET HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET FUC A 604 11 HET EDO B 601 4 HET EDO B 602 4 HET EDO B 603 4 HET FUC B 604 11 HETNAM EDO 1,2-ETHANEDIOL HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN EDO ETHYLENE GLYCOL HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 EDO 6(C2 H6 O2) FORMUL 6 FUC 2(C6 H12 O5) FORMUL 11 HOH *747(H2 O) HELIX 1 AA1 THR A 233 MET A 237 5 5 HELIX 2 AA2 SER A 279 ILE A 283 5 5 HELIX 3 AA3 ALA A 359 LEU A 362 5 4 HELIX 4 AA4 PRO A 454 ALA A 465 1 12 HELIX 5 AA5 THR B 233 MET B 237 5 5 HELIX 6 AA6 SER B 279 ILE B 283 5 5 HELIX 7 AA7 ALA B 359 LEU B 362 5 4 HELIX 8 AA8 PRO B 454 ALA B 465 1 12 SHEET 1 A 3 LYS A 248 THR A 251 0 SHEET 2 A 3 LEU A 432 THR A 437 -1 SHEET 3 A 3 ASP A 448 CYS A 451 -1 SHEET 1 B 6 ARG A 364 GLU A 368 0 SHEET 2 B 6 ASN A 298 LEU A 303 -1 SHEET 3 B 6 PHE A 286 HIS A 292 -1 SHEET 4 B 6 THR A 381 VAL A 388 -1 SHEET 5 B 6 LYS A 329 THR A 337 -1 SHEET 6 B 6 THR A 344 TYR A 352 -1 SHEET 1 C 5 GLU A 429 LEU A 431 0 SHEET 2 C 5 TYR A 496 ALA A 500 -1 SHEET 3 C 5 VAL A 485 HIS A 492 -1 SHEET 4 C 5 VAL A 472 VAL A 478 -1 SHEET 5 C 5 TYR A 514 VAL A 521 -1 SHEET 1 D 3 LYS B 248 THR B 251 0 SHEET 2 D 3 LEU B 432 THR B 437 -1 SHEET 3 D 3 ASP B 448 CYS B 451 -1 SHEET 1 E 6 ARG B 364 GLU B 368 0 SHEET 2 E 6 ASN B 298 LEU B 303 -1 SHEET 3 E 6 PHE B 286 HIS B 292 -1 SHEET 4 E 6 THR B 381 VAL B 388 -1 SHEET 5 E 6 LYS B 329 THR B 337 -1 SHEET 6 E 6 THR B 344 TYR B 352 -1 SHEET 1 F 5 GLU B 429 LEU B 431 0 SHEET 2 F 5 TYR B 496 ALA B 500 -1 SHEET 3 F 5 VAL B 485 HIS B 492 -1 SHEET 4 F 5 VAL B 472 VAL B 478 -1 SHEET 5 F 5 TYR B 514 VAL B 521 -1 CISPEP 1 GLU A 399 PRO A 400 0 -7.15 CISPEP 2 GLU B 399 PRO B 400 0 -7.22 CRYST1 99.070 55.570 115.510 90.00 107.28 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010094 0.000000 0.003139 0.00000 SCALE2 0.000000 0.017995 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009066 0.00000